<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epidemiological studies demonstrate a prevalence of Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§ets disease (MAB) in the range of 0.12-420 per 100,000 inhabitants with the highest rates in Istanbul, Turkey and the lowest rates in the USA </plain></SENT>
<SENT sid="1" pm="."><plain>Ophthalmological data on the prevalence of ocular involvement are limited for MAB in Germany because most epidemiological studies are based on rheumatological or dermatological data </plain></SENT>
<SENT sid="2" pm="."><plain>Berlin is the city with the highest number of non-native German inhabitants and its multiethnic character renders it uniquely appropriate for epidemiological studies on MAB </plain></SENT>
<SENT sid="3" pm="."><plain>This article summarizes the most important epidemiological data of 140 patients (63 female and 77 male) with a mean follow-up of 6.4 years (range 0.5-22 years) which we have recently published </plain></SENT>
<SENT sid="4" pm="."><plain>The mean age was 23 years at the first manifestation and 32 years when the fully developed disease was recorded </plain></SENT>
<SENT sid="5" pm="."><plain>The mean age at <z:hpo ids='HP_0003674'>onset</z:hpo> of ocular involvement was 30 years, 56% of patients developed ocular involvement, which was the first manifestation in 8.6% and the second manifestation in 19.3% </plain></SENT>
<SENT sid="6" pm="."><plain>More than half the patients developed ocular involvement </plain></SENT>
<SENT sid="7" pm="."><plain>The calculated prevalence of ocular involvement in MAB is 1.77/100,000 inhabitants for the population of Berlin </plain></SENT>
</text></document>